Clinical Trial Update: Study of TVEC in Patients With Cutaneous Squamous Cell Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for talimogene laherparepvec (T-VEC) in patients with cutaneous squamous cell carcinoma; the study has completed and results were …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of the Skin

Drugs mentioned

• T-VEC (talimogene laherparepvec)

Snippet

Sponsor: University of Arizona | Conditions: Squamous Cell Carcinoma, Skin Cancer | Phase 2 | Status: COMPLETED | Results posted: 2024-10-09